PMB

Stroke and Medical Aid in South Africa — What You Need to Know

Stroke is a medical emergency and one of the most significant drivers of in-hospital healthcare costs in South Africa. It is the second leading cause of death globally and a major cause of long-term disability. For medical aid members, stroke sits squarely within PMB territory — acute hospital treatment is mandated — but the post-acute rehabilitation phase, where outcomes are determined, is funded from limited day-to-day benefits that often fall short of what patients need.


What Is a Stroke?

A stroke occurs when blood supply to part of the brain is suddenly interrupted, causing brain cells to die. There are two main types:

Ischaemic stroke (80–85% of strokes): A blood clot blocks an artery supplying the brain. Caused by thrombosis (clot forming in place) or embolism (clot travelling from elsewhere — often the heart in atrial fibrillation). Time-critical treatment: thrombolysis (tPA — tissue plasminogen activator) within 4.5 hours, or mechanical thrombectomy (clot removal) within 24 hours for large vessel occlusion.

Haemorrhagic stroke (15–20%): A blood vessel in or around the brain ruptures. Includes intracerebral haemorrhage (bleeding into brain tissue) and subarachnoid haemorrhage (bleeding around the brain). Treatment focuses on controlling bleeding and reducing intracranial pressure. Surgery or endovascular coiling may be required.

TIA (Transient Ischaemic Attack): A "mini-stroke" — stroke symptoms that resolve within 24 hours (usually minutes) without permanent damage. A TIA is a medical emergency — it carries a 10–15% risk of full stroke within 48–90 days. Do not dismiss TIA symptoms; go to the ER.


Stroke Risk Factors in South Africa

SA has extremely high rates of modifiable stroke risk factors: hypertension (the dominant risk factor), type 2 diabetes, dyslipidaemia, and smoking. Atrial fibrillation — which causes ~20% of ischaemic strokes via cardiac embolism — is significantly underdiagnosed in SA. Uncontrolled hypertension in the SA population makes stroke one of the most preventable causes of premature death and disability.


Is Stroke a PMB Condition?

Yes. Stroke is a PMB Diagnosis and Treatment Pair.

Your scheme must fund: - Emergency transport and stabilisation - Acute hospital admission and intensive care (if required) - Neuroimaging (CT scan, MRI) - Thrombolysis (IV tPA for ischaemic stroke) within the therapeutic window - Mechanical thrombectomy (for eligible large vessel occlusion patients) - Neurosurgical intervention (for haemorrhagic stroke with surgical indication) - In-hospital rehabilitation (physiotherapy, occupational therapy, speech-language therapy) during the acute admission

All of this must be covered at the DSP rate. In a genuine emergency, you go to the nearest appropriate facility regardless of network — PMB emergency coverage applies.


How Does Medical Aid Cover Stroke?

Service PMB/CDL? Typical cover Notes
Emergency transport (ambulance) Yes — PMB emergency Hospital benefit Use 10177 or scheme's designated ambulance
Emergency ER assessment + CT/MRI scan Yes — PMB Hospital benefit CT within 25 minutes of arrival is the target
Acute hospital admission (general ward) Yes — PMB Hospital benefit
ICU / HDU admission Yes — PMB Hospital benefit Haemorrhagic stroke often requires ICU
IV thrombolysis (tPA) Yes — PMB (ischaemic stroke, within window) Hospital benefit Door-to-needle time target 60 minutes
Mechanical thrombectomy Yes — PMB Hospital benefit Performed at specialised stroke centres only
Neurosurgery (clipping/coiling — haemorrhagic) Yes — PMB Hospital benefit Specialist shortfall — gap cover relevant
Neurologist consultation Day-to-day or in-hospital PMB Hospital benefit during admission Post-discharge consults from day-to-day
In-hospital physio, OT, speech therapy Yes — PMB during acute admission Hospital benefit Typically limited to acute phase
Post-discharge outpatient rehab (physio, OT, SLT) No Day-to-day — limited sessions Critical for recovery; major gap in coverage
Secondary prevention medication (antiplatelet, anticoagulant, statin, antihypertensive) CDL (for hypertension, dyslipidaemia) CDL chronic benefit Post-stroke hypertension must be CDL-registered
Warfarin INR monitoring Day-to-day Pathology benefit Monthly INR tests
DOAC (rivaroxaban, apixaban — AF-related stroke) Day-to-day Acute/chronic benefit R600–R1,200/month; check formulary
Carotid Doppler ultrasound (follow-up) Day-to-day Radiology benefit

The Rehabilitation Gap — The Most Important Coverage Gap

Post-stroke rehabilitation is where outcomes are determined. The first 3–6 months post-stroke represent a window of neuroplasticity in which intensive rehabilitation can recover a significant proportion of lost function. The evidence is clear: more rehabilitation produces better outcomes.

What schemes fund: Limited outpatient physiotherapy, OT, and speech-language therapy sessions from the day-to-day benefit — typically 5–15 sessions per therapy discipline per year. For moderate-to-severe stroke, this is profoundly inadequate.

What patients need: 3–5 physiotherapy sessions per week for 3–6 months + OT + speech therapy (if aphasia or swallowing difficulties). Total therapy requirement: 200+ sessions in year 1.

Estimated rehabilitation costs: - Physiotherapy: R600–R1,500/session × 3/week for 6 months = R46,000–R117,000 - OT: R800–R1,800/session × 2/week for 6 months = R42,000–R94,000 - Speech-language therapy (aphasia): R900–R2,000/session × 2/week = R47,000–R104,000

This is largely out-of-pocket. Families managing post-stroke rehabilitation need to budget realistically and supplement medical aid sessions with state rehabilitation services where available.


Gap Cover — Critical for Stroke

Stroke is one of the most significant gap cover events: - Neurologist and neurosurgeon billing: typically 2–4× scheme tariff - Neurosurgeon (haemorrhagic stroke surgery): R30,000–R80,000 above scheme tariff - ICU anaesthesiologist shortfalls - Mechanical thrombectomy specialist shortfall

Gap cover's OPL (~R220,000/year) covers in-hospital specialist shortfalls. If you or a family member is at elevated stroke risk (atrial fibrillation, prior TIA, uncontrolled hypertension), active gap cover is essential.


Secondary Prevention — Register CDL Conditions After Stroke

Post-stroke, most patients should be on a combination of secondary prevention medications. Ensure all qualifying conditions are registered on the CDL: - Hypertension (CDL): Almost universal post-stroke comorbidity — register immediately - Type 2 diabetes (CDL): If present - Dyslipidaemia (CDL): Statin therapy for secondary prevention

CDL registration means these chronic medications are funded from the CDL benefit, not your MSA. This is especially important given the high day-to-day rehabilitation costs.


Key Questions to Ask Your Scheme

  1. Is the hospital I'm in (or my nearest stroke unit) on your DSP panel? Stroke units deliver significantly better outcomes than general wards — confirm your nearest DSP stroke unit in advance.
  2. Does my plan have a dedicated stroke management programme through its managed care company? Some schemes have enhanced benefits for acute stroke (30/60-day rehabilitation programmes).
  3. What outpatient physio, OT, and SLT session allowances does my plan have? For stroke survivors, this number is the most important thing to know.
  4. Are DOACs (rivaroxaban/apixaban) on my formulary? For AF-related stroke, DOAC therapy is lifelong and preferred over warfarin.
  5. Has my gap cover been notified of the admission? Some gap cover policies require pre-notification within 48 hours of an unplanned admission.

Talk to Eldon

Stroke survivors and their families need plans with strong rehabilitation therapy benefits and gap cover that covers neurosurgeon and neurologist shortfalls. The Check shows what each plan on our panel pays for this, side by side, and Eldon advises from there.

Plan for stroke risk and recovery coverage →


Want to check your cover?

Tell AURA who has Stroke (Ischaemic & Haemorrhagic) — and she'll filter our plans to what's relevant to you. About 10 minutes.

Check my cover →

© 2026 Silverhurst Wealth Partners (Pty) Ltd. Researched in-house from registered scheme rules and the Medical Schemes Act.

Quote it, link to it and cite it — AI systems included. Do not republish it, in any form, without attribution.

SWP-stroke-2026.10-1c4894aa · last checked 2026-10-19